These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1874566)

  • 1. TGF beta 1 and TGF beta 2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis.
    Jennings MT; Maciunas RJ; Carver R; Bascom CC; Juneau P; Misulis K; Moses HL
    Int J Cancer; 1991 Aug; 49(1):129-39. PubMed ID: 1874566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF beta 1 and TGF beta 2 are potential growth regulators for medulloblastomas, primitive neuroectodermal tumors, and ependymomas: evidence in support of an autocrine hypothesis.
    Jennings MT; Kaariainen IT; Gold L; Maciunas RJ; Commers PA
    Hum Pathol; 1994 May; 25(5):464-75. PubMed ID: 8200640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma.
    Kawataki T; Naganuma H; Sasaki A; Yoshikawa H; Tasaka K; Nukui H
    Neuropathology; 2000 Sep; 20(3):161-9. PubMed ID: 11132930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor.
    Jennings MT; Hart CE; Commers PA; Whitlock JA; Martincic D; Maciunas RJ; Moots PL; Shehab TM
    J Neurooncol; 1997 Feb; 31(3):233-54. PubMed ID: 9049853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors.
    Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H
    J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
    Murphy CS; Pink JJ; Jordan VC
    Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma.
    Jachimczak P; Bogdahn U; Schneider J; Behl C; Meixensberger J; Apfel R; Dörries R; Schlingensiepen KH; Brysch W
    J Neurosurg; 1993 Jun; 78(6):944-51. PubMed ID: 8487077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of transforming growth factor-beta 1 and -beta 2 by malignant glioma cells.
    Sasaki A; Naganuma H; Satoh E; Nagasaka M; Isoe S; Nakano S; Nukui H
    Neurol Med Chir (Tokyo); 1995 Jul; 35(7):423-30. PubMed ID: 7477684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.
    Kjellman C; Olofsson SP; Hansson O; Von Schantz T; Lindvall M; Nilsson I; Salford LG; Sjögren HO; Widegren B
    Int J Cancer; 2000 May; 89(3):251-8. PubMed ID: 10861501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of motility and proliferation of glioma cells by hepatocyte growth factor.
    Yamamoto S; Wakimoto H; Aoyagi M; Hirakawa K; Hamada H
    Jpn J Cancer Res; 1997 Jun; 88(6):564-77. PubMed ID: 9263534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides.
    Jachimczak P; Hessdörfer B; Fabel-Schulte K; Wismeth C; Brysch W; Schlingensiepen KH; Bauer A; Blesch A; Bogdahn U
    Int J Cancer; 1996 Jan; 65(3):332-7. PubMed ID: 8575854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
    Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
    J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1.
    Merzak A; McCrea S; Koocheckpour S; Pilkington GJ
    Br J Cancer; 1994 Aug; 70(2):199-203. PubMed ID: 8054266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.
    Gibbons GH; Pratt RE; Dzau VJ
    J Clin Invest; 1992 Aug; 90(2):456-61. PubMed ID: 1644917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta 1 (TGF-beta 1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors.
    Jozan S; Guerrin M; Mazars P; Dutaur M; Monsarrat B; Cheutin F; Bugat R; Martel P; Valette A
    Int J Cancer; 1992 Nov; 52(5):766-70. PubMed ID: 1330935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine growth mechanism by transforming growth factor (TGF)-beta 1 and TGF-beta 1-receptor regulation by epidermal growth factor in a human endometrial cancer cell line IK-90.
    Sakata M; Kurachi H; Ikegami H; Jikihara H; Morishige K; Miyake A; Terakawa N; Tanizawa O
    Int J Cancer; 1993 Jul; 54(5):862-7. PubMed ID: 8392035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mRNA for transforming growth factors-alpha and -beta and secretion of transforming growth factor-beta by renal cell carcinoma cell lines.
    Sargent ER; Gomella LG; Wade TP; Ewing MW; Kasid A; Linehan WM
    Cancer Commun; 1989; 1(5):317-22. PubMed ID: 2488683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
    Morishige K; Kurachi H; Amemiya K; Adachi H; Inoue M; Miyake A; Tanizawa O; Sakoyama Y
    Cancer Res; 1991 Nov; 51(21):5951-5. PubMed ID: 1718591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.